Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2019 June;71(3) > Minerva Ginecologica 2019 June;71(3):211-23



To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Ginecologica 2019 June;71(3):211-23

DOI: 10.23736/S0026-4784.19.04404-6


language: English

Criteria, phenotypes and prevalence of polycystic ovary syndrome

Liliia V. BELENKAIA 1, Lyudmila M. LAZAREVA 1, Walidah WALKER 2, Daria V. LIZNEVA 3, Larisa V. SUTURINA 1

1 Department of Reproductive Health Protection, Scientific Center for Family Health and Human Reproduction, Irkutsk, Russia; 2 Research Administration Office, Augusta University, Augusta, GA, USA; 3 Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, USA

Polycystic ovarian syndrome (PCOS) is known as one of the most frequent endocrine diseases in women worldwide. However, this term does not completely capture the diversity of clinical signs associated with this syndrome e.g., menstrual irregularity and clinical features of androgen excess, which are though commonplace in women with PCOS, they are not included under the definition of PCOS, limited to polycystic ovarian morphology (PCOM). Utilizing the most globally accepted criterion used today in the diagnosis of PCOS, the authors of this article review and discuss the historical and current context of evidence as well as their limitations. This review addresses the phenotypic approach and age-dependent aspects of PCOS in adolescents, adult and peri/postmenopausal women, as presented in the NIH (1990, 2012), Rotterdam (2003), AE-PCOS Society (2006) consensuses and in the latest evidence-based international guideline (2018). Global data on the epidemiology of PCOS, including prevalence and distribution of polycystic ovarian syndrome phenotypes, is also analyzed in the article. Lastly, the authors discuss the importance and current need to perform more epidemiological studies focused on PCOS.

KEY WORDS: Polycystic ovary syndrome; Prevalence; Phenotype

top of page